Led a final year project on *Investigation of In Vitro Screening for Antidiabetic, Anti-microbial, Anticancer activity against A549 human lung cancer cell line &Structural analysis (FTIR & GC-MS) of Achyranthes aspera*.
Conducted phytochemical characterization and biological evaluation of *Achyranthes aspera* extract, identifying major bioactive constituents via FT-IR spectroscopy and GC-MS analysis.
Assessed diverse biological activities, including antimicrobial, antioxidant (ABTS radical scavenging), and antidiabetic (α-amylase inhibition).
Validated anticancer effects against A549 human lung cancer cells using MTT assay, fluorescence staining, and flow cytometry to evaluate apoptosis and cell cycle arrest.
Demonstrated a strong correlation between chemical composition and multifunctional biological activities, highlighting plant-derived compounds' therapeutic potential.